Global Epidemiology of Hepatitis B Virus Infection

Lavanchy, Daniel; Kane, Mark

doi:10.1007/978-3-319-22330-8_9

Cited by 80 publications

(82 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hepatitis B can causes both acute and chronic liver disease and is a major cause of mortality and morbidity [7]. It is one of the major diseases of mankind, estimated to cause about 800,000 deaths per year mostly from liver cancer and cirrhosis [8]. This represents a decrease of 31 % in hepatitis B surface antigen (HBsAg) prevalence as compared to the former published figures of 350-400 million [8].…”

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

“…It is one of the major diseases of mankind, estimated to cause about 800,000 deaths per year mostly from liver cancer and cirrhosis [8]. This represents a decrease of 31 % in hepatitis B surface antigen (HBsAg) prevalence as compared to the former published figures of 350-400 million [8]. The history of the epidemiology of hepatitis B represents a landmark in the general understanding of viral infections, their distributions and their outcomes.…”

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

“…The history of the epidemiology of hepatitis B represents a landmark in the general understanding of viral infections, their distributions and their outcomes. In 2010 and 2014 resolutions of the World Health Assembly, have acknowledged at the political level that viral hepatitis is a global public health problem, ranking HBV as the 15 th cause of death in all cause of global mortality [8]. The global prevalence of chronic carriage varies between 0.1 and more than 20% [6].…”

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

See 2 more Smart Citations

Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh

Alam¹

2017

GHOA

View full text Add to dashboard Cite

Chronic hepatitis B (HBV) is one of the major diseases of mankind, estimated to cause about 686,000 deaths per year mostly from liver cancer and cirrhosis. And globally about 240 million people are chronically infected with hepatitis B. Nonalcoholic fatty liver disease (NAFLD) is an emerging commonest cause of chronic liver disease in the world. We have searched for CHB, NAFLD in PUBMED, Google scholar and local journals and related available articles were included in this review. Along with 184 countries of the world Bangladesh adopted hepatitis B vaccine in his EPI (expanded program on immunization) schedule for its prevention. And now about 95% of children are under cover of Hepatitis vaccine. Along with globally in last two decades' seroprevalence of HBsAg reduced about four times in Bangladesh. The prevalence of recorded nonalcoholic fatty liver disease (NAFLD) varies considerably by ethnic group and Bangladeshi ethnicity is an independent risk factor for NAFLD. The prevalence of NAFLD in Bangladesh is vary from 4%-18.4% and it is increasing day by day. About 40% of them are nonalcoholic steatohepatitis (NASH). They are in danger of progression to cirrhosis and hepatocellular carcinoma (15-19%) in next 5 to 10 years. Now it's becoming a silent killer for our nation. Gradual development of affluence, sedentary life style and increasing prevalence of diabetes contributed behind it. No effective treatment is available till now. Life style change by diet, exercise and weight reduction is the main stay of treatment. NAFLD involve multiple organs that leads to death due to cardiac, neurological and liver disease. Government and health department should take multidisciplinary action programs in awareness building and make a national guideline for fatty liver management.

show abstract

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

Section: Global Epidemiology Of Hepatitis B and Fatty Livermentioning

confidence: 99%

See 1 more Smart Citation

Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh

Alam¹

2017

GHOA

View full text Add to dashboard Cite

show abstract

“…Most of the patients had suffered from hepatitis B, ranging between 1 to 30 years. All demographic features are demonstrated in Table 1.…”

Section: Ethical Considerationsmentioning

confidence: 99%

A Qualitative Study on Marital Challenges of Chronic Hepatitis B Patients

Hassani

Ezbarami

Tafreshi

et al. 2017

Iran Red Crescent Med J

View full text Add to dashboard Cite

Background: Hepatitis B is a life-threatening viral infection that is mainly transmitted through blood; due to the presence of this virus in semen, vaginal fluids, and saliva, the possibility of transmission among couples during marital life still exists. Objectives: This study was conducted to specify the patients' perception of their marital problems. Methods: In this descriptive qualitative research conducted in Iran, 32 patients with chronic hepatitis B were selected through purposive sampling. The data were collected through semi-structured interviews and field notes during 23 months in 2015 and 2016. The interview transcripts were coded by using MAXQDA10 software®. The utilization of thematic analysis approach was to extract categories and themes. Results: Participants of this study were in the chronic and inactive phase of hepatitis B. Participants' age varied from 24 to 57 years. Three major themes were extracted: premarriage challenges, conjugal life with suffering, and lack of marital adjustment. Conclusions: Like other chronic diseases, chronic hepatitis B causes numerous marital challenges for the carriers of the disease. The partners of patients with hepatitis B can be used as self-care facilitating agents in the family to promote self-care of these patients and help better manage their marital challenges.

show abstract

“…Currently, there are 350 million carriers of HBV around the world (3). Each year, 877 000 people die due to the serious complications of HBV infection, including cirrhosis and hepatocellular carcinoma (4).…”

Section: Introductionmentioning

confidence: 99%

The Prevalence and Risk Factors of Type II Diabetes Mellitus Among Patients with Hepatitis B Virus: A Descriptive Correlational Study

et al. 2017

View full text Add to dashboard Cite

Background: There are 350 million carriers of hepatitis B virus (HBV) around the world. HBV can be associated with type II diabetes mellitus. The aim of this study was to evaluate the prevalence and risk factors for type II diabetes mellitus among patients with HBV. Methods: This community-based, cross sectional, descriptive, correlational study recruited participants above 13 years, who resided in Esfandiar rural area, Tabas, Iran. A blood sample was collected from each participant for serological and biochemical tests. A researcher-made questionnaire was used to collect data on the participants' demographic characteristics, HBV risk factors, and diabetes mellitus risk factors. Independent sample t test, Chi square test, and Fisher's exact test were applied in SPSS v. 22.0 at a significance level of < 0.05.

show abstract

Global Epidemiology of Hepatitis B Virus Infection

Cited by 80 publications

References 86 publications

Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh

Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh

A Qualitative Study on Marital Challenges of Chronic Hepatitis B Patients

The Prevalence and Risk Factors of Type II Diabetes Mellitus Among Patients with Hepatitis B Virus: A Descriptive Correlational Study

Contact Info

Product

Resources

About